Redox control of cardiac remodeling in atrial fibrillation

Biochimica et Biophysica Acta - General Subjects

Volumn 1850, Issue 8, 2015, Pages 1555-1565

  Wolke, Carmen ^a   Bukowska, Alicja ^b   Goette, Andreas ^b,c   Lendeckel, Uwe ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^c St Vincenz Hospital   (Germany)

Author keywords

Atrial fibrillation; Atrial remodeling; Redox regulation; ROS

Indexed keywords

REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ANIMAL; ATRIAL FIBRILLATION; HEART; HEART MUSCLE; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ATRIAL FIBRILLATION; HEART; HUMANS; METABOLISM; MYOCARDIUM; OXIDATION-REDUCTION; PATHOLOGY; PHYSIOPATHOLOGY; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84939980049     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.12.012     Document Type: Review

References (240)

1. A. Goette, A. Bukowska, C.H. Lillig, and U. Lendeckel Oxidative stress and microcirculatory flow abnormalities in the ventricles during atrial fibrillation Front. Physiol. 3 2012 236
2. P. Ghezzi, V. Bonetto, and M. Fratelli Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation Antioxid. Redox Signal. 7 2005 964 972
3. D.P. Jones Redefining oxidative stress Antioxid. Redox Signal. 8 2006 1865 1879
4. D.P. Jones Radical-free biology of oxidative stress Am. J. Physiol. Cell Physiol. 295 2008 C849 C868
5. R.P. Brandes, N. Weissmann, and K. Schroder Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases J. Mol. Cell. Cardiol. 73 2014 70 79
6. C.X. Huang, Y. Liu, W.F. Xia, Y.H. Tang, and H. Huang Oxidative stress: a possible pathogenesis of atrial fibrillation Med. Hypotheses 72 2009 466 467
7. J. Li, J. Solus, Q. Chen, Y.H. Rho, G. Milne, C.M. Stein, and D. Darbar Role of inflammation and oxidative stress in atrial fibrillation Heart rhythm 7 2010 438 444
8. N.R. Madamanchi, and M.S. Runge Redox signaling in cardiovascular health and disease Free Radic. Biol. Med. 61C 2013 473 501
9. S. Negi, A.A. Sovari, and S.C. Dudley Jr. Atrial fibrillation: the emerging role of inflammation and oxidative stress Cardiovasc. Hematol. Disord. Drug Targets 10 2010 262 268
10. B. Ramlawi, H. Otu, S. Mieno, M. Boodhwani, N.R. Sodha, R.T. Clements, C. Bianchi, and F.W. Sellke Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study Ann. Thorac. Surg. 84 2007 1166 1172 (discussion 1172-1163)
11. C.M. Sag, C.X. Santos, and A.M. Shah Redox regulation of cardiac hypertrophy J. Mol. Cell. Cardiol. 73 2014 103 111
12. C.X. Santos, N. Anilkumar, M. Zhang, A.C. Brewer, and A.M. Shah Redox signaling in cardiac myocytes Free Radic. Biol. Med. 50 2011 777 793
13. D.R. Van Wagoner Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target J. Cardiovasc. Pharmacol. 52 2008 306 313
14. K.C. Yang, and S.C. Dudley Jr. Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle Circulation 128 2013 1724 1726
15. J.Y. Youn, J. Zhang, Y. Zhang, H. Chen, D. Liu, P. Ping, J.N. Weiss, and H. Cai Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase J. Mol. Cell. Cardiol. 62 2013 72 79
16. M. Zhang, A. Perino, A. Ghigo, E. Hirsch, and A.M. Shah NADPH oxidases in heart failure: poachers or gamekeepers? Antioxid. Redox Signal. 18 2013 1024 1041
17. C.A. Carnes, M.K. Chung, T. Nakayama, H. Nakayama, R.S. Baliga, S. Piao, A. Kanderian, S. Pavia, R.L. Hamlin, P.M. McCarthy, J.A. Bauer, and D.R. Van Wagoner Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation Circ. Res. 89 2001 E32 E38
18. M.J. Mihm, F. Yu, C.A. Carnes, P.J. Reiser, P.M. McCarthy, D.R. Van Wagoner, and J.A. Bauer Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180
19. D. Cesselli, I. Jakoniuk, L. Barlucchi, A.P. Beltrami, T.H. Hintze, B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy Circ. Res. 89 2001 279 286
20. L. Schild, A. Bukowska, A. Gardemann, P. Polczyk, G. Keilhoff, M. Tager, S.C. Dudley, H.U. Klein, A. Goette, and U. Lendeckel Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism-a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia Biochim. Biophys. Acta 1762 2006 608 615
21. A. Bukowska, L. Schild, G. Keilhoff, D. Hirte, M. Neumann, A. Gardemann, K.H. Neumann, F.W. Rohl, C. Huth, A. Goette, and U. Lendeckel Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia Exp. Biol. Med. 233 2008 558 574
22. R. Ben Abraham, M. Matza, S. Marmor, V. Rudick, I. Frolkis, I. Shapira, and A.A. Weinbroum Electromechanical impairment of human auricle and rat myocardial strip subjected to exogenous oxidative stress Eur. J. Cardiothorac. Surg. 23 2003 66 73
23. N.S. Dhalla, and R.M. Temsah Sarcoplasmic reticulum and cardiac oxidative stress: an emerging target for heart disease Expert Opin. Ther. Targets 5 2001 205 217
24. N.S. Dhalla, R.M. Temsah, and T. Netticadan Role of oxidative stress in cardiovascular diseases J. Hypertens. 18 2000 655 673
25. S.H. Loh, J.S. Jin, C.S. Tsai, C.M. Chao, Y. Tsai, W.H. Chen, T.H. Cheng, C.C. Chuang, and C.I. Lin Possible underlying mechanism for hydrogen peroxide-induced electromechanical suppression in human atrial myocardium J. Pharmacol. Sci. 91 2003 53 60
26. Y.H. Kim, D.S. Lim, J.H. Lee, W.J. Shim, Y.M. Ro, G.H. Park, K.G. Becker, Y.S. Cho-Chung, and M.K. Kim Gene expression profiling of oxidative stress on atrial fibrillation in humans Exp. Mol. Med. 35 2003 336 349
27. P.H. Lin, S.H. Lee, C.P. Su, and Y.H. Wei Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation Free Radic. Biol. Med. 35 2003 1310 1318
28. J. Ausma, M. Wijffels, F. Thone, L. Wouters, M. Allessie, and M. Borgers Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat Circulation 96 1997 3157 3163
29. S.H. Loh, Y.T. Tsai, C.Y. Lee, C.Y. Chang, C.S. Tsai, T.H. Cheng, and C.I. Lin Antiarrhythmic effects of dehydroevodiamine in isolated human myocardium and cardiomyocytes J. Ethnopharmacol. 153 2014 753 762
30. A. Bukowska, M. Hammwohner, A. Sixdorf, L. Schild, I. Wiswedel, F.W. Rohl, C. Wolke, U. Lendeckel, C. Aderkast, S. Bochmann, R.K. Chilukoti, J. Mostertz, P. Bramlage, and A. Goette Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs Br. J. Pharmacol. 166 2012 964 980
31. A. Goette, A. Bukowska, D. Dobrev, J. Pfeiffenberger, H. Morawietz, D. Strugala, I. Wiswedel, F.W. Rohl, C. Wolke, S. Bergmann, P. Bramlage, U. Ravens, and U. Lendeckel Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles Eur. Heart J. 30 2009 1411 1420
32. A.I. De Souza, S. Cardin, R. Wait, Y.L. Chung, M. Vijayakumar, A. Maguy, A.J. Camm, and S. Nattel Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure J. Mol. Cell. Cardiol. 49 2010 851 863
33. E. Cadenas, and K.J. Davies Mitochondrial free radical generation, oxidative stress, and aging Free Radic. Biol. Med. 29 2000 222 230
34. P. Schonfeld, M.R. Wieckowski, M. Lebiedzinska, and L. Wojtczak Mitochondrial fatty acid oxidation and oxidative stress: lack of reverse electron transfer-associated production of reactive oxygen species Biochim. Biophys. Acta 1797 2010 929 938
35. R.P. Mason, I.T. Mak, M.F. Walter, T.N. Tulenko, and P.E. Mason Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil Biochem. Pharmacol. 55 1998 1843 1852
36. T.J. Collins, P. Lipp, M.J. Berridge, and M.D. Bootman Mitochondrial Ca(2 +) uptake depends on the spatial and temporal profile of cytosolic Ca(2 +) signals J. Biol. Chem. 276 2001 26411 26420
37. A.P. Halestrap Calcium, mitochondria and reperfusion injury: a pore way to die Biochem. Soc. Trans. 34 2006 232 237
38. U. Ravens, G.S. Liu, G. Vandeplassche, and M. Borgers Protection of human, rat, and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2 + Cardiovasc. Drugs. Ther. 6 1992 47 58
39. K. Kawahara, M. Takase, and Y. Yamauchi Ruthenium red-induced transition from ventricular fibrillation to tachycardia in isolated rat hearts: possible involvement of changes in mitochondrial calcium uptake J. Cardiovasc. Pathol. 12 2003 311 321
40. L. Rivard, H. Sinno, A. Shiroshita-Takeshita, G. Schram, T.K. Leung, and S. Nattel The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy Cardiovasc. Res. 74 2007 104 113
41. H. Sinno, K. Derakhchan, D. Libersan, Y. Merhi, T.K. Leung, and S. Nattel Atrial ischemia promotes atrial fibrillation in dogs Circulation 107 2003 1930 1936
42. K. Nishida, X.Y. Qi, R. Wakili, P. Comtois, D. Chartier, M. Harada, Y.K. Iwasaki, P. Romeo, A. Maguy, D. Dobrev, G. Michael, M. Talajic, and S. Nattel Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model Circulation 123 2011 137 146
43. Y.K. Lin, M.S. Lai, Y.C. Chen, C.C. Cheng, J.H. Huang, S.A. Chen, Y.J. Chen, and C.I. Lin Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium Clin. Sci. 122 2012 121 132
44. I. Afanas'ev ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxidative Med. Cell. Longev. 2011 2011 293769
45. B.M. Babior, J.D. Lambeth, and W. Nauseef The neutrophil NADPH oxidase Arch. Biochem. Biophys. 397 2002 342 344
46. K.K. Griendling, D. Sorescu, and M. Ushio-Fukai NAD(P)H oxidase: role in cardiovascular biology and disease Circ. Res. 86 2000 494 501
47. E.A. Jaimes, J.M. Galceran, and L. Raij Angiotensin II induces superoxide anion production by mesangial cells Kidney Int. 54 1998 775 784
48. K. Yasunari, K. Maeda, M. Nakamura, and J. Yoshikawa Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress Hypertension 39 2002 433 437
49. J.M. Li, N.P. Gall, D.J. Grieve, M. Chen, and A.M. Shah Activation of NADPH oxidase during progression of cardiac hypertrophy to failure Hypertension 40 2002 477 484
50. K. Matsuno, H. Yamada, K. Iwata, D. Jin, M. Katsuyama, M. Matsuki, S. Takai, K. Yamanishi, M. Miyazaki, H. Matsubara, and C. Yabe-Nishimura Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice Circulation 112 2005 2677 2685
51. L. Serrander, L. Cartier, K. Bedard, B. Banfi, B. Lardy, O. Plastre, A. Sienkiewicz, L. Forro, W. Schlegel, and K.H. Krause NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation Biochem. J. 406 2007 105 114
52. T.V. Murray, I. Smyrnias, A.M. Shah, and A.C. Brewer NADPH oxidase 4 regulates cardiomyocyte differentiation via redox activation of c-Jun protein and the cis-regulation of GATA-4 gene transcription J. Biol. Chem. 288 2013 15745 15759
53. T. Ago, J. Kuroda, J. Pain, C. Fu, H. Li, and J. Sadoshima Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes Circ. Res. 106 2010 1253 1264
54. J. Kuroda, T. Ago, S. Matsushima, P. Zhai, M.D. Schneider, and J. Sadoshima NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart Proc. Natl. Acad. Sci. U. S. A. 107 2010 15565 15570
55. Y. Zhang, H. Shimizu, K.L. Siu, A. Mahajan, J.N. Chen, and H. Cai NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafish J. Biol. Chem. 289 2014 23200 23208
56. A. Dikalova, R. Clempus, B. Lassegue, G. Cheng, J. McCoy, S. Dikalov, A. San Martin, A. Lyle, D.S. Weber, D. Weiss, W.R. Taylor, H.H. Schmidt, G.K. Owens, J.D. Lambeth, and K.K. Griendling Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice Circulation 112 2005 2668 2676
57. D.X. Zhang, K. Ren, Y. Guan, Y.T. Wang, and Z.L. Shan Protective effects of apocynin on atrial electrical remodeling and oxidative stress in a rabbit rapid atrial pacing model Chin. J. Physiol. 57 2014 76 82
58. M. Sakabe, A. Fujiki, T. Sakamoto, Y. Nakatani, K. Mizumaki, and H. Inoue Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction J. Cardiovasc. Electrophysiol. 23 2012 1130 1135
59. E.J. Anderson, J.T. Efird, S.W. Davies, W.T. O'Neal, T.M. Darden, K.A. Thayne, L.A. Katunga, L.C. Kindell, T.B. Ferguson, C.A. Anderson, W.R. Chitwood, T.C. Koutlas, J.M. Williams, E. Rodriguez, and A.P. Kypson Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation J. Am. Heart Assoc. 3 2014 e000713
60. S.N. Reilly, R. Jayaram, K. Nahar, C. Antoniades, S. Verheule, K.M. Channon, N.J. Alp, U. Schotten, and B. Casadei Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins Circulation 124 2011 1107 1117
61. J.F. Gielis, J.Y. Lin, K. Wingler, P.E. Van Schil, H.H. Schmidt, and A.L. Moens Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders Free Radic. Biol. Med. 50 2011 765 776
62. A. Reif, L.G. Frohlich, P. Kotsonis, A. Frey, H.M. Bommel, D.A. Wink, W. Pfleiderer, and H.H. Schmidt Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase J. Biol. Chem. 274 1999 24921 24929
63. H. Cai, Z. Li, A. Goette, F. Mera, C. Honeycutt, K. Feterik, J.N. Wilcox, S.C. Dudley Jr., D.G. Harrison, and J.J. Langberg Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2002 2854 2858
64. T. Minamino, M. Kitakaze, H. Sato, H. Asanuma, H. Funaya, Y. Koretsune, and M. Hori Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation Arterioscler. Thromb. Vasc. Biol. 17 1997 3191 3195
65. D. Nikitovic, E.A. Zacharis, E.G. Manios, N.E. Malliaraki, E.M. Kanoupakis, K.I. Sfiridaki, E.I. Skalidis, A.N. Margioris, and P.E. Vardas Plasma levels of nitrites/nitrates in patients with chronic atrial fibrillation are increased after electrical restoration of sinus rhythm J. Interv. Card. Electr. 7 2002 171 176
66. A. Goette, M. Hammwohner, A. Bukowska, F. Scalera, J. Martens-Lobenhoffer, D. Dobrev, U. Ravens, S. Weinert, S. Medunjanin, U. Lendeckel, and S.M. Bode-Boger The impact of rapid atrial pacing on ADMA and endothelial NOS Int. J. Cardiol. 154 2012 141 146
67. N. Kamiyama Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation: rabbit experimental model Jpn. Circ. J. 62 1998 837 843
68. A. Shiroshita-Takeshita, B.J. Brundel, J. Lavoie, and S. Nattel Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs Cardiovasc. Res. 69 2006 865 875
69. I. Lenaerts, R.B. Driesen, N. Hermida, P. Holemans, H. Heidbuchel, S. Janssens, J.L. Balligand, K.R. Sipido, and R. Willems Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation Europace 15 2013 754 760
70. M. Bedi, D. McNamara, B. London, and D. Schwartzman Genetic susceptibility to atrial fibrillation in patients with congestive heart failure Heart rhythm 3 2006 808 812
71. C. Fatini, E. Sticchi, M. Genuardi, F. Sofi, F. Gensini, A.M. Gori, M. Lenti, A. Michelucci, R. Abbate, and G.F. Gensini Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation Eur. Heart J. 27 2006 1712 1718
72. F. Gensini, L. Padeletti, C. Fatini, E. Sticchi, G.F. Gensini, and A. Michelucci Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation Pacing Clin. Electrophysiol. PACE 26 2003 295 298
73. B. Giusti, A.M. Gori, R. Marcucci, I. Sestini, C. Saracini, E. Sticchi, F. Gensini, C. Fatini, R. Abbate, and G.F. Gensini Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility PLoS ONE 2 2007 e495
74. H. Chen, H. Chu, Y. Shi, S.S. Bhuyan, J. Li, S.R. Liu, and J. Yang Association between endothelial nitric oxide synthase polymorphisms and atrial fibrillation: a meta-analysis J. Cardiovasc. Transl. Res. 5 2012 528 534
75. H. Liu, X. Qu, Z. Liang, W. Chen, W. Xia, and Y. Song Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs Biochem. Biophys. Res. Commun. 377 2008 884 888
76. Q. Feng, X. Lu, A.J. Fortin, A. Pettersson, T. Hedner, R.L. Kline, and J.M. Arnold Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure Cardiovasc. Res. 37 1998 667 675
77. M. Saitoh, T. Osanai, T. Kamada, T. Matsunaga, H. Ishizaka, H. Hanada, and K. Okumura High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level Heart Vessel. 18 2003 177 182
78. T. Yamashita, A. Sekiguchi, T. Kato, T. Tsuneda, Y.K. Iwasaki, K. Sagara, H. Iinuma, H. Sawada, and T. Aizawa Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats J. Renin Angiotensin Aldosterone Syst.: JRAAS 8 2007 127 132
79. H.S. Kim, C.W. No, S.H. Goo, and T.J. Cha An Angiotensin receptor blocker prevents arrhythmogenic left atrial remodeling in a rat post myocardial infarction induced heart failure model J. Korean Med. Sci. 28 2013 700 708
80. A. Bukowska, C. Rocken, M. Erxleben, F.W. Rohl, M. Hammwohner, C. Huth, M.P. Ebert, U. Lendeckel, and A. Goette Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation J. Cardiovasc. Pathol. 19 2010 e51 e60
81. N. Kaludercic, A. Carpi, T. Nagayama, V. Sivakumaran, G. Zhu, E.W. Lai, D. Bedja, A. De Mario, K. Chen, K.L. Gabrielson, M.L. Lindsey, K. Pacak, E. Takimoto, J.C. Shih, D.A. Kass, F. Di Lisa, and N. Paolocci Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts Antioxid. Redox Signal. 20 2014 267 280
82. N. Kaludercic, E. Takimoto, T. Nagayama, N. Feng, E.W. Lai, D. Bedja, K. Chen, K.L. Gabrielson, R.D. Blakely, J.C. Shih, K. Pacak, D.A. Kass, F. Di Lisa, and N. Paolocci Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload Circ. Res. 106 2010 193 202
83. A. Purohit, A.G. Rokita, X. Guan, B. Chen, O.M. Koval, N. Voigt, S. Neef, T. Sowa, Z. Gao, E.D. Luczak, H. Stefansdottir, A.C. Behunin, N. Li, R.N. El-Accaoui, B. Yang, P.D. Swaminathan, R.M. Weiss, X.H. Wehrens, L.S. Song, D. Dobrev, L.S. Maier, and M.E. Anderson Oxidized Ca(2 +)/calmodulin-dependent protein kinase II triggers atrial fibrillation Circulation 128 2013 1748 1757
84. E.D. Luczak, and M.E. Anderson CaMKII oxidative activation and the pathogenesis of cardiac disease J. Mol. Cell. Cardiol. 73 2014 112 116
85. S. Neef, N. Dybkova, S. Sossalla, K.R. Ort, N. Fluschnik, K. Neumann, R. Seipelt, F.A. Schondube, G. Hasenfuss, and L.S. Maier CaMKII-dependent diastolic SR Ca2 + leak and elevated diastolic Ca2 + levels in right atrial myocardium of patients with atrial fibrillation Circ. Res. 106 2010 1134 1144
86. G. Gao, and S.C. Dudley Jr. Redox regulation, NF-kappaB, and atrial fibrillation Antioxid. Redox Signal. 11 2009 2265 2277
87. L.L. Shang, and S.C. Dudley Jr. Tandem promoters and developmentally regulated 5'- and 3'-mRNA untranslated regions of the mouse Scn5a cardiac sodium channel J. Biol. Chem. 280 2005 933 940
88. L.L. Shang, S. Sanyal, A.E. Pfahnl, Z. Jiao, J. Allen, H. Liu, and S.C. Dudley Jr. NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II Am. J. Physiol. Cell Physiol. 294 2008 C372 C379
89. A. Bowie, and L.A. O'Neill Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries Biochem. Pharmacol. 59 2000 13 23
90. R.E. Dolmetsch, K. Xu, and R.S. Lewis Calcium oscillations increase the efficiency and specificity of gene expression Nature 392 1998 933 936
91. C. Kunsch, and R.M. Medford Oxidative stress as a regulator of gene expression in the vasculature Circ. Res. 85 1999 753 766
92. B. Burstein, E. Libby, A. Calderone, and S. Nattel Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences Circulation 117 2008 1630 1641
93. O. Adam, D. Lavall, K. Theobald, M. Hohl, M. Grube, S. Ameling, M.A. Sussman, S. Rosenkranz, H.K. Kroemer, H.J. Schafers, M. Bohm, and U. Laufs Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation J. Am. Coll. Cardiol. 55 2010 469 480
94. D.J. Sulciner, K. Irani, Z.X. Yu, V.J. Ferrans, P. Goldschmidt-Clermont, and T. Finkel rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation Mol. Cell. Biol. 16 1996 7115 7121
95. D. Yang, J. Yuan, G. Liu, Z. Ling, H. Zeng, Y. Chen, Y. Zhang, Q. She, and X. Zhou Angiotensin receptor blockers and statins could alleviate atrial fibrosis via regulating platelet-derived growth factor/Rac1/nuclear factor-kappa B Axis Int.J. Med. Sci. 10 2013 812 824
96. C.C. Lin, L.L. Chiang, C.H. Lin, C.H. Shih, Y.T. Liao, M.J. Hsu, and B.C. Chen Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells Eur. J. Pharmacol. 560 2007 101 109
97. R. Tyrrell Redox regulation and oxidant activation of heme oxygenase-1 Free Radic. Res. 31 1999 335 340
98. T. Ishii, K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai, and M. Yamamoto Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages J. Biol. Chem. 275 2000 16023 16029
99. S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2 J. Cell Sci. 116 2003 665 674
100. D. Martin, R. Galisteo, and J.S. Gutkind CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex J. Biol. Chem. 284 2009 6038 6042
101. D.M. Lawrence, P. Seth, L. Durham, F. Diaz, R. Boursiquot, R.M. Ransohoff, and E.O. Major Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells Glia 53 2006 81 91
102. S. Bonello, C. Zahringer, R.S. BelAiba, T. Djordjevic, J. Hess, C. Michiels, T. Kietzmann, and A. Gorlach Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site Arterioscler. Thromb. Vasc. Biol. 27 2007 755 761
103. X.B. Qiu, Y.M. Shao, S. Miao, and L. Wang The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones Cell. Moll. Life Sci.: CMLS 63 2006 2560 2570
104. D.A. Bloom, and A.K. Jaiswal Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression J. Biol. Chem. 278 2003 44675 44682
105. X. Cheng, C.H. Ku, and R.C. Siow Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis Free Radic. Biol. Med. 64 2013 4 11
106. M.A. Mori, P. Raghavan, T. Thomou, J. Boucher, S. Robida-Stubbs, Y. Macotela, S.J. Russell, J.L. Kirkland, T.K. Blackwell, and C.R. Kahn Role of microRNA processing in adipose tissue in stress defense and longevity Cell Metab. 16 2012 336 347
107. Z. Ungvari, Z. Tucsek, D. Sosnowska, P. Toth, T. Gautam, A. Podlutsky, A. Csiszar, G. Losonczy, M.N. Valcarcel-Ares, W.E. Sonntag, and A. Csiszar Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells J. Gerontol. A: Biol. Med. Sci. 68 2013 877 891
108. J.L. Wiesen, and T.B. Tomasi Dicer is regulated by cellular stresses and interferons Mol. Immunol. 46 2009 1222 1228
109. G. Santulli, G. Iaccarino, N. De Luca, B. Trimarco, and G. Condorelli Atrial fibrillation and microRNAs Front. Physiol. 5 2014 15
110. Y. Liang, D. Ridzon, L. Wong, and C. Chen Characterization of microRNA expression profiles in normal human tissues BMC Genomics 8 2007 166
111. Y. Lu, Y. Zhang, N. Wang, Z. Pan, X. Gao, F. Zhang, Y. Zhang, H. Shan, X. Luo, Y. Bai, L. Sun, W. Song, C. Xu, Z. Wang, and B. Yang MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation Circulation 122 2010 2378 2387
112. Z. Wang, Y. Lu, and B. Yang MicroRNAs and atrial fibrillation: new fundamentals Cardiovasc. Res. 89 2011 710 721
113. H. Liu, G.X. Chen, M.Y. Liang, H. Qin, J. Rong, J.P. Yao, and Z.K. Wu Atrial fibrillation alters the microRNA expression profiles of the left atria of patients with mitral stenosis BMC Cardiovasc. Disord. 14 2014 10
114. H. Liu, H. Qin, G.X. Chen, M.Y. Liang, J. Rong, J.P. Yao, and Z.K. Wu Comparative expression profiles of microRNA in left and right atrial appendages from patients with rheumatic mitral valve disease exhibiting sinus rhythm or atrial fibrillation J. Transl. Med. 12 2014 90
115. V. Roldan, A.B. Arroyo, S. Salloum-Asfar, S. Manzano-Fernandez, N. Garcia-Barbera, F. Marin, V. Vicente, R. Gonzalez-Conejero, and C. Martinez Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation Thromb. Haemost. 112 2014
116. W. Kimura, and H.A. Sadek The cardiac hypoxic niche: emerging role of hypoxic microenvironment in cardiac progenitors Cardiovasc. Drugs. Ther. 2 2012 278 289
117. Z. Arany, S.Y. Foo, Y. Ma, J.L. Ruas, A. Bommi-Reddy, G. Girnun, M. Cooper, D. Laznik, J. Chinsomboon, S.M. Rangwala, K.H. Baek, A. Rosenzweig, and B.M. Spiegelman HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha Nature 451 2008 1008 1012
118. N. Ferrara, G. Frantz, J. LeCouter, L. Dillard-Telm, T. Pham, A. Draksharapu, T. Giordano, and F. Peale Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries Am. J. Pathol 162 2003 1881 1893
119. O. Adam, K. Theobald, D. Lavall, M. Grube, H.K. Kroemer, S. Ameling, H.J. Schafers, M. Bohm, and U. Laufs Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation J. Mol. Cell. Cardiol. 50 2011 678 685
120. I.K. Hornstra, S. Birge, B. Starcher, A.J. Bailey, R.P. Mecham, and S.D. Shapiro Lysyl oxidase is required for vascular and diaphragmatic development in mice J. Biol. Chem. 278 2003 14387 14393
121. J.M. Maki, J. Rasanen, H. Tikkanen, R. Sormunen, K. Makikallio, K.I. Kivirikko, and R. Soininen Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice Circulation 106 2002 2503 2509
122. C. Rodriguez, J.F. Alcudia, J. Martinez-Gonzalez, B. Raposo, M.A. Navarro, and L. Badimon Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction Atherosclerosis 196 2008 558 564
123. L.I. Smith-Mungo, and H.M. Kagan Lysyl oxidase: properties, regulation and multiple functions in biology Matrix Biol. 16 1998 387 398
124. W. Li, K. Nellaiappan, T. Strassmaier, L. Graham, K.M. Thomas, and H.M. Kagan Localization and activity of lysyl oxidase within nuclei of fibrogenic cells Proc. Natl. Acad. Sci. U. S. A. 94 1997 12817 12822
125. C. Rodriguez, J. Martinez-Gonzalez, B. Raposo, J.F. Alcudia, A. Guadall, and L. Badimon Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases Cardiovasc. Res. 79 2008 7 13
126. H.M. Lazarus, W.W. Cruikshank, N. Narasimhan, H.M. Kagan, and D.M. Center Induction of human monocyte motility by lysyl oxidase Matrix biology 14 1995 727 731
127. W. Li, G. Liu, I.N. Chou, and H.M. Kagan Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells J. Cell. Biochem. 78 2000 550 557
128. E. Leistad, G. Aksnes, E. Verburg, and G. Christensen Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644 Circulation 93 1996 1747 1754
129. X.Y. Qi, Y.H. Yeh, L. Xiao, B. Burstein, A. Maguy, D. Chartier, L.R. Villeneuve, B.J. Brundel, D. Dobrev, and S. Nattel Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current Circ. Res. 103 2008 845 854
130. U. Schotten, J. Ausma, C. Stellbrink, I. Sabatschus, M. Vogel, D. Frechen, F. Schoendube, P. Hanrath, and M.A. Allessie Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation Circulation 103 2001 691 698
131. H. Sun, R. Gaspo, N. Leblanc, and S. Nattel Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia Circulation 98 1998 719 727
132. U. Schotten, S. Verheule, P. Kirchhof, and A. Goette Pathophysiological mechanisms of atrial fibrillation: a translational appraisal Physiol. Rev. 91 2011 265 325
133. S. Nattel, A. Maguy, S. Le Bouter, and Y.H. Yeh Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation Physiol. Rev. 87 2007 425 456
134. A.J. Workman, K.A. Kane, and A.C. Rankin Cellular bases for human atrial fibrillation Heart rhythm 5 2008 S1 S6
135. D.R. Gonzalez, A. Treuer, Q.A. Sun, J.S. Stamler, and J.M. Hare S-Nitrosylation of cardiac ion channels J. Cardiovasc. Pharmacol. 54 2009 188 195
136. B. Lima, M.T. Forrester, D.T. Hess, and J.S. Stamler S-nitrosylation in cardiovascular signaling Circ. Res. 106 2010 633 646
137. R.F. Bosch, X. Zeng, J.B. Grammer, K. Popovic, C. Mewis, and V. Kuhlkamp Ionic mechanisms of electrical remodeling in human atrial fibrillation Cardiovasc. Res. 44 1999 121 131
138. B.J. Brundel, I.C. Van Gelder, R.H. Henning, R.G. Tieleman, A.E. Tuinenburg, M. Wietses, J.G. Grandjean, W.H. Van Gilst, and H.J. Crijns Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation Circulation 103 2001 684 690
139. M. Skasa, E. Jungling, E. Picht, F. Schondube, and A. Luckhoff L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation Basic Res. Cardiol. 96 2001 151 159
140. D.R. Van Wagoner, A.L. Pond, M. Lamorgese, S.S. Rossie, P.M. McCarthy, and J.M. Nerbonne Atrial L-type Ca2 + currents and human atrial fibrillation Circ. Res. 85 1999 428 436
141. R.F. Bosch, C.R. Scherer, N. Rub, S. Wohrl, K. Steinmeyer, H. Haase, A.E. Busch, L. Seipel, and V. Kuhlkamp Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca, L) and I(to) in rapid atrial pacing in rabbits J. Am. Coll. Cardiol. 41 2003 858 869
142. B.J. Brundel, I.C. Van Gelder, R.H. Henning, A.E. Tuinenburg, M. Wietses, J.G. Grandjean, A.A. Wilde, W.H. Van Gilst, and H.J. Crijns Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K + channels J. Am. Coll. Cardiol. 37 2001 926 932
143. H.M.W. van der Velden, L. van der Zee, M.C. Wijffels, C. van Leuven, R. Dorland, M.A. Vos, H.J. Jongsma, and M.A. Allessie Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization J. Cardiovasc. Electrophysiol. 11 2000 1262 1269
144. L. Yue, P. Melnyk, R. Gaspo, Z. Wang, and S. Nattel Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation Circ. Res. 84 1999 776 784
145. B.J. Brundel, H.H. Kampinga, and R.H. Henning Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation Cardiovasc. Res. 62 2004 521 528
146. T. Christ, P. Boknik, S. Wohrl, E. Wettwer, E.M. Graf, R.F. Bosch, M. Knaut, W. Schmitz, U. Ravens, and D. Dobrev L-type Ca2 + current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases Circulation 110 2004 2651 2657
147. U. Schotten, H. Haase, D. Frechen, M. Greiser, C. Stellbrink, J.F. Vazquez-Jimenez, I. Morano, M.A. Allessie, and P. Hanrath The L-type Ca2 + -channel subunits alpha1C and beta2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation J. Mol. Cell. Cardiol. 35 2003 437 443
148. J. Sun, M. Morgan, R.F. Shen, C. Steenbergen, and E. Murphy Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport Circ. Res. 101 2007 1155 1163
149. C.A. Carnes, P.M. Janssen, M.L. Ruehr, H. Nakayama, T. Nakayama, H. Haase, J.A. Bauer, M.K. Chung, I.M. Fearon, A.M. Gillinov, R.L. Hamlin, and D.R. Van Wagoner Atrial glutathione content, calcium current, and contractility J. Biol. Chem. 282 2007 28063 28073
150. H. Reuter, and H. Scholz A study of the ion selectivity and the kinetic properties of the calcium dependent slow inward current in mammalian cardiac muscle J. Physiol. 264 1977 17 47
151. N. Sperelakis, and J.A. Schneider A metabolic control mechanism for calcium ion influx that may protect the ventricular myocardial cell Am. J. Cardiol. 37 1976 1079 1085
152. T.J. Kamp, and J.W. Hell Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C Circ. Res. 87 2000 1095 1102
153. P.F. Mery, N. Abi-Gerges, G. Vandecasteele, J. Jurevicius, T. Eschenhagen, and R. Fischmeister Muscarinic regulation of the L-type calcium current in isolated cardiac myocytes Life Sci. 60 1997 1113 1120
154. A. Sculptoreanu, E. Rotman, M. Takahashi, T. Scheuer, and W.A. Catterall Voltage-dependent potentiation of the activity of cardiac L-type calcium channel alpha 1 subunits due to phosphorylation by cAMP-dependent protein kinase Proc. Natl. Acad. Sci. U. S. A. 90 1993 10135 10139
155. B.D. Johnson, T. Scheuer, and W.A. Catterall Voltage-dependent potentiation of L-type Ca2 + channels in skeletal muscle cells requires anchored cAMP-dependent protein kinase Proc. Natl. Acad. Sci. U. S. A. 91 1994 11492 11496
156. J.G. Murphy, J.L. Sanderson, J.A. Gorski, J.D. Scott, W.A. Catterall, W.A. Sather, and M.L. Dell'Acqua AKAP-anchored PKA maintains neuronal L-type calcium channel activity and NFAT transcriptional signaling Cell Rep. 7 2014 1577 1588
157. B. Fiedler, S.M. Lohmann, A. Smolenski, S. Linnemuller, B. Pieske, F. Schroder, J.D. Molkentin, H. Drexler, and K.C. Wollert Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes Proc. Natl. Acad. Sci. U. S. A. 99 2002 11363 11368
158. J.D. Molkentin Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs Cardiovasc. Res. 63 2004 467 475
159. B.J. Wilkins, Y.S. Dai, O.F. Bueno, S.A. Parsons, J. Xu, D.M. Plank, F. Jones, T.R. Kimball, and J.D. Molkentin Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy Circ. Res. 94 2004 110 118
160. A. Bukowska, U. Lendeckel, D. Hirte, C. Wolke, F. Striggow, P. Rohnert, C. Huth, H.U. Klein, and A. Goette Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation Cell Mol. Life Sci.: CMLS 63 2006 333 342
161. Y. Fu, R.E. Westenbroek, T. Scheuer, and W.A. Catterall Phosphorylation sites required for regulation of cardiac calcium channels in the fight-or-flight response Proc. Natl. Acad. Sci. U. S. A. 110 2013 19621 19626
162. E. Minobe, S. Maeda, J.J. Xu, L.Y. Hao, A. Kameyama, and M. Kameyama A new phosphorylation site in cardiac L-type Ca2 + channels (Cav1.2) responsible for its cAMP-mediated modulation Am. J. Physiol. Cell Physiol. 307 11 2014 c999 c1009 (ajpcell 00267 02014).
163. L. Yang, A. Katchman, T. Samad, J.P. Morrow, R.L. Weinberg, and S.O. Marx beta-adrenergic regulation of the L-type Ca2 + channel does not require phosphorylation of alpha1C Ser1700 Circ. Res. 113 2013 871 880
164. G. Klein, F. Schroder, D. Vogler, A. Schaefer, A. Haverich, B. Schieffer, T. Korte, and H. Drexler Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation. role of phosphatase 2A Cardiovasc. Res. 59 2003 37 45
165. F. Schroder, G. Klein, B. Fiedler, M. Bastein, N. Schnasse, A. Hillmer, S. Ames, S. Gambaryan, H. Drexler, U. Walter, S.M. Lohmann, and K.C. Wollert Single L-type Ca(2 +) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice Cardiovasc. Res. 60 2003 268 277
166. J.G. Akar, T.H. Everett, R. Ho, J. Craft, D.E. Haines, A.P. Somlyo, and A.V. Somlyo Intracellular chloride accumulation and subcellular elemental distribution during atrial fibrillation Circulation 107 2003 1810 1815
167. J.A. Vest, X.H. Wehrens, S.R. Reiken, S.E. Lehnart, D. Dobrev, P. Chandra, P. Danilo, U. Ravens, M.R. Rosen, and A.R. Marks Defective cardiac ryanodine receptor regulation during atrial fibrillation Circulation 111 2005 2025 2032
168. L. Hove-Madsen, A. Llach, A. Bayes-Genis, S. Roura, E. Rodriguez Font, A. Aris, and J. Cinca Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes Circulation 110 2004 1358 1363
169. N. Li, T. Wang, W. Wang, M.J. Cutler, Q. Wang, N. Voigt, D.S. Rosenbaum, D. Dobrev, and X.H. Wehrens Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice Circ. Res. 110 2012 465 470
170. P. Aracena, W. Tang, S.L. Hamilton, and C. Hidalgo Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels Antioxid. Redox Signal. 7 2005 870 881
171. J. Sun, C. Xin, J.P. Eu, J.S. Stamler, and G. Meissner Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO Proc. Natl. Acad. Sci. U. S. A. 98 2001 11158 11162
172. J.P. Eu, J. Sun, L. Xu, J.S. Stamler, and G. Meissner The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions Cell 102 2000 499 509
173. J. Sun, N. Yamaguchi, L. Xu, J.P. Eu, J.S. Stamler, and G. Meissner Regulation of the cardiac muscle ryanodine receptor by O(2) tension and S-nitrosoglutathione Biochemistry 47 2008 13985 13990
174. D.R. Gonzalez, F. Beigi, A.V. Treuer, and J.M. Hare Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes Proc. Natl. Acad. Sci. U. S. A. 104 2007 20612 20617
175. S.R. Mazurek, E. Bovo, and A.V. Zima Regulation of sarcoplasmic reticulum Ca(2 +) release by cytosolic glutathione in rabbit ventricular myocytes Free Radic. Biol. Med. 68 2014 159 167
176. N. Voigt, J. Heijman, Q. Wang, D.Y. Chiang, N. Li, M. Karck, X.H. Wehrens, S. Nattel, and D. Dobrev Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation Circulation 129 2014 145 156
177. K. Cao, X. Xia, Q. Shan, Z. Chen, X. Chen, and Y. Huang Changes of sarcoplamic reticular Ca(2 +)-ATPase and IP(3)-I receptor mRNA expression in patients with atrial fibrillation Chin. Med. J. 115 2002 664 667
178. U. Schotten, M. Greiser, D. Benke, K. Buerkel, B. Ehrenteidt, C. Stellbrink, J.F. Vazquez-Jimenez, F. Schoendube, P. Hanrath, and M. Allessie Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort Cardiovasc. Res. 53 2002 192 201
179. T.V. Knyushko, V.S. Sharov, T.D. Williams, C. Schoneich, and D.J. Bigelow 3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment Biochemistry 44 2005 13071 13081
180. M.M. Thomas, C. Vigna, A.C. Betik, A.R. Tupling, and R.T. Hepple Cardiac calcium pump inactivation and nitrosylation in senescent rat myocardium are not attenuated by long-term treadmill training Exp. Gerontol. 46 2011 803 810
181. N. Voigt, N. Li, Q. Wang, W. Wang, A.W. Trafford, I. Abu-Taha, Q. Sun, T. Wieland, U. Ravens, S. Nattel, X.H. Wehrens, and D. Dobrev Enhanced sarcoplasmic reticulum Ca2 + leak and increased Na + -Ca2 + exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation Circulation 125 2012 2059 2070
182. M. Gao, J. Wang, Z. Wang, Y. Zhang, H. Sun, X. Xie, and Y. Hou An altered expression of genes involved in the regulation of ion channels in atrial myocytes is correlated with the risk of atrial fibrillation in patients with heart failure Exp. Ther. Med. 5 2013 1239 1243
183. Y. Okamoto, M. Takano, T. Ohba, and K. Ono Arrhythmogenic coupling between the Na + -Ca2 + exchanger and inositol 1,4,5-triphosphate receptor in rat pulmonary vein cardiomyocytes J. Mol. Cell. Cardiol. 52 2012 988 997
184. C.T. Tsai, F.T. Chiang, W.P. Chen, J.J. Hwang, C.D. Tseng, C.K. Wu, C.C. Yu, Y.C. Wang, L.P. Lai, and J.L. Lin Angiotensin II induces complex fractionated electrogram in a cultured atrial myocyte monolayer mediated by calcium and sodium-calcium exchanger Cell Calcium 49 2011 1 11
185. J.P. Reeves, C.A. Bailey, and C.C. Hale Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles J. Biol. Chem. 261 1986 4948 4955
186. I.M. Dixon, M. Kaneko, T. Hata, V. Panagia, and N.S. Dhalla Alterations in cardiac membrane Ca2 + transport during oxidative stress Mol. Cell. Biochem. 99 1990 125 133
187. T. Liu, and B. O'Rourke Regulation of the Na +/Ca2 + exchanger by pyridine nucleotide redox potential in ventricular myocytes J. Biol. Chem. 288 2013 31984 31992
188. A. Secondo, P. Molinaro, A. Pannaccione, A. Esposito, M. Cantile, P. Lippiello, R. Sirabella, T. Iwamoto, G. Di Renzo, and L. Annunziato Nitric oxide stimulates NCX1 and NCX2 but inhibits NCX3 isoform by three distinct molecular determinants Mol. Pharmacol. 79 2011 558 568
189. F. Beigi, D.R. Gonzalez, K.M. Minhas, Q.A. Sun, M.W. Foster, S.A. Khan, A.V. Treuer, R.A. Dulce, R.W. Harrison, R.M. Saraiva, C. Premer, I.H. Schulman, J.S. Stamler, and J.M. Hare Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function Proc. Natl. Acad. Sci. U. S. A. 109 2012 4314 4319
190. J. Kockskamper, A.V. Zima, H.L. Roderick, B. Pieske, L.A. Blatter, and M.D. Bootman Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes J. Mol. Cell. Cardiol. 45 2008 128 147
191. Z. Zeng, H. Zhang, N. Lin, M. Kang, Y. Zheng, C. Li, P. Xu, Y. Wu, and D. Luo Role of inositol-1,4,5-trisphosphate receptor in the regulation of calcium transients in neonatal rat ventricular myocytes J. Pharmacol. Sci. 126 2014 37 46
192. J. Kockskamper, L. Seidlmayer, S. Walther, K. Hellenkamp, L.S. Maier, and B. Pieske Endothelin-1 enhances nuclear Ca2 + transients in atrial myocytes through Ins(1,4,5)P3-dependent Ca2 + release from perinuclear Ca2 + stores J. Cell Sci. 121 2008 186 195
193. X. Li, A.V. Zima, F. Sheikh, L.A. Blatter, and J. Chen Endothelin-1-induced arrhythmogenic Ca2 + signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice Circ. Res. 96 2005 1274 1281
194. D. Roman-Campos, H.L. Duarte, E.R. Gomes, C.H. Castro, S. Guatimosim, A.J. Natali, A.P. Almeida, J.B. Pesquero, J.L. Pesquero, and J.S. Cruz Investigation of the cardiomyocyte dysfunction in bradykinin type 2 receptor knockout mice Life Sci. 87 2010 715 723
195. S.A. Maher, E.D. Dubuis, and M.G. Belvisi G-protein coupled receptors regulating cough Curr. Opin. Pharmacol. 11 2011 248 253
196. P. Liu, R.L. Hopfner, Y.J. Xu, and V. Gopalakrishnan Vasopressin-evoked [Ca2 +]i responses in neonatal rat cardiomyocytes J. Cardiovasc. Pharmacol. 34 1999 540 546
197. D.J. Bare, C.S. Kettlun, M. Liang, D.M. Bers, and G.A. Mignery Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II J. Biol. Chem. 280 2005 15912 15920
198. J. Liu, Z.Y. He, S.M. Xu, F.Y. Liu, and P.Y. Wang Inositol 1,4,5-triphosphate receptors (IP(3)Rs) in myocardial nuclei involved in pressure overload-induced hypertrophy of rat heart Sheng li xue bao:[Acta physiologica Sinica] 53 2001 281 285
199. S. Ljubojevic, S. Radulovic, G. Leitinger, S. Sedej, M. Sacherer, M. Holzer, C. Winkler, E. Pritz, T. Mittler, A. Schmidt, M. Sereinigg, P. Wakula, S. Zissimopoulos, E. Bisping, H. Post, G. Marsche, J. Bossuyt, D.M. Bers, J. Kockskamper, and B. Pieske Early remodeling of perinuclear Ca2 + stores and nucleoplasmic Ca2 + signaling during the development of hypertrophy and heart failure Circulation 130 2014 244 255
200. J. Bossuyt, K. Helmstadter, X. Wu, H. Clements-Jewery, R.S. Haworth, M. Avkiran, J.L. Martin, S.M. Pogwizd, and D.M. Bers Ca2 +/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure Circ. Res. 102 2008 695 702
201. S.A. Akhter, L.M. Luttrell, H.A. Rockman, G. Iaccarino, R.J. Lefkowitz, and W.J. Koch Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy Science 280 1998 574 577
202. H. Ito, Y. Hirata, M. Hiroe, M. Tsujino, S. Adachi, T. Takamoto, M. Nitta, K. Taniguchi, and F. Marumo Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes Circ. Res. 69 1991 209 215
203. P.H. Sugden, and A. Clerk Endothelin signalling in the cardiac myocyte and its pathophysiological relevance Curr. Vasc. Pharmacol. 3 2005 343 351
204. J.H. Guo, Y.S. Liu, H.C. Zhang, X.B. Li, Y. Xu, Y.Y. Zhang, and L. Yuan Expression and function changes of ryanodine receptors and inositol 1,4,5-triphosphate receptors of atrial myocytes during atrial fibrillation Zhonghua yi xue za zhi 84 2004 1196 1199
205. X. Liang, H. Xie, P.H. Zhu, J. Hu, Q. Zhao, C.S. Wang, and C. Yang Enhanced activity of inositol-1,4,5-trisphosphate receptors in atrial myocytes of atrial fibrillation patients Cardiology 114 2009 180 191
206. J. Xiao, D. Liang, H. Zhao, Y. Liu, H. Zhang, X. Lu, Y. Liu, J. Li, L. Peng, and Y.H. Chen 2-Aminoethoxydiphenyl borate, a inositol 1,4,5-triphosphate receptor inhibitor, prevents atrial fibrillation Exp. Biol. Med. 235 2010 862 868
207. S.K. Joseph Role of thiols in the structure and function of inositol trisphosphate receptors Curr. Top. Membr. 66 2010 299 322
208. G.S. Bird, G.M. Burgess, and J.W. Putney Jr. Sulfhydryl reagents and cAMP-dependent kinase increase the sensitivity of the inositol 1,4,5-trisphosphate receptor in hepatocytes J. Biol. Chem. 268 1993 17917 17923
209. M.D. Bootman, C.W. Taylor, and M.J. Berridge The thiol reagent, thimerosal, evokes Ca2 + spikes in HeLa cells by sensitizing the inositol 1,4,5-trisphosphate receptor J. Biol. Chem. 267 1992 25113 25119
210. G. Bultynck, K. Szlufcik, N.N. Kasri, Z. Assefa, G. Callewaert, L. Missiaen, J.B. Parys, and H. De Smedt Thimerosal stimulates Ca2 + flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2 + -dependent intramolecular interaction Biochem. J. 381 2004 87 96
211. S.A. Khan, A.M. Rossi, A.M. Riley, B.V. Potter, and C.W. Taylor Subtype-selective regulation of IP(3) receptors by thimerosal via cysteine residues within the IP(3)-binding core and suppressor domain Biochem. J. 451 2013 177 184
212. J.T. Lock, W.G. Sinkins, and W.P. Schilling Effect of protein S-glutathionylation on Ca2 + homeostasis in cultured aortic endothelial cells Am. J. Physiol. Heart Circ. Physiol. 300 2011 H493 H506
213. J.T. Lock, W.G. Sinkins, and W.P. Schilling Protein S-glutathionylation enhances Ca2 + -induced Ca2 + release via the IP3 receptor in cultured aortic endothelial cells J. Physiol. 590 2012 3431 3447
214. S. Bansaghi, T. Golenar, M. Madesh, G. Csordas, S. RamachandraRao, K. Sharma, D.I. Yule, S.K. Joseph, and G. Hajnoczky Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species J. Biol. Chem. 289 2014 8170 8181
215. S.L. Archer, M. Gomberg-Maitland, M.L. Maitland, S. Rich, J.G. Garcia, and E.K. Weir Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer Am. J. Physiol. Heart Circ. Physiol. 294 2008 H570 H578
216. S.Q. Cai, and F. Sesti Oxidation of a potassium channel causes progressive sensory function loss during aging Nat. Neurosci. 12 2009 611 617
217. C. Schach, M. Xu, O. Platoshyn, S.H. Keller, and J.X. Yuan Thiol oxidation causes pulmonary vasodilation by activating K + channels and inhibiting store-operated Ca2 + channels Am. J. Physiol. Lung Cell Mol. Physiol. 292 2007 L685 L698
218. L.K. Svoboda, K.G. Reddie, L. Zhang, E.D. Vesely, E.S. Williams, S.M. Schumacher, R.P. O'Connell, R. Shaw, S.M. Day, J.M. Anumonwo, K.S. Carroll, and J.R. Martens Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5 Circ. Res. 111 2012 842 853
219. M.A. Ciorba, S.H. Heinemann, H. Weissbach, N. Brot, and T. Hoshi Modulation of potassium channel function by methionine oxidation and reduction Proc. Natl. Acad. Sci. U. S. A. 94 1997 9932 9937
220. K. Asada, J. Kurokawa, and T. Furukawa Redox- and calmodulin-dependent S-nitrosylation of the KCNQ1 channel J. Biol. Chem. 284 2009 6014 6020
221. C.X. Bai, I. Namekata, J. Kurokawa, H. Tanaka, K. Shigenobu, and T. Furukawa Role of nitric oxide in Ca2 + sensitivity of the slowly activating delayed rectifier K + current in cardiac myocytes Circ. Res. 96 2005 64 72
222. C.X. Bai, K. Takahashi, H. Masumiya, T. Sawanobori, and T. Furukawa Nitric oxide-dependent modulation of the delayed rectifier K + current and the L-type Ca2 + current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes Br. J. Pharmacol. 142 2004 567 575
223. L. Nunez, M. Vaquero, R. Gomez, R. Caballero, P. Mateos-Caceres, C. Macaya, I. Iriepa, E. Galvez, A. Lopez-Farre, J. Tamargo, and E. Delpon Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism Cardiovasc. Res. 72 2006 80 89
224. R. Gomez, L. Nunez, M. Vaquero, I. Amoros, A. Barana, T. de Prada, C. Macaya, L. Maroto, E. Rodriguez, R. Caballero, A. Lopez-Farre, J. Tamargo, and E. Delpon Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1) Cardiovasc. Res. 80 2008 375 384
225. M. Kassmann, A. Hansel, E. Leipold, J. Birkenbeil, S.Q. Lu, T. Hoshi, and S.H. Heinemann Oxidation of multiple methionine residues impairs rapid sodium channel inactivation Pflugers Arch. - Eur. J. Physiol. 456 2008 1085 1095
226. K. Fukuda, S.S. Davies, T. Nakajima, B.H. Ong, S. Kupershmidt, J. Fessel, V. Amarnath, M.E. Anderson, P.A. Boyden, P.C. Viswanathan, L.J. Roberts II, and J.R. Balser Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels Circ. Res. 97 2005 1262 1269
227. S. Wagner, H.M. Ruff, S.L. Weber, S. Bellmann, T. Sowa, T. Schulte, M.E. Anderson, E. Grandi, D.M. Bers, J. Backs, L. Belardinelli, and L.S. Maier Reactive oxygen species-activated Ca/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and Ca overload Circ. Res. 108 2011 555 565
228. G.P. Ahern, S.F. Hsu, V.A. Klyachko, and M.B. Jackson Induction of persistent sodium current by exogenous and endogenous nitric oxide J. Biol Chem. 275 2000 28810 28815
229. Y. Kurata, I. Hisatome, M. Tsuboi, H. Uenishi, G. Zhang, M. Oyaizu, R. Sato, and S. Imanishi Effect of sulfhydryl oxidoreduction on permeability of cardiac tetrodotoxin-insensitive sodium channel Life Sci. 63 1998 1023 1035
230. C.M. Sag, S. Wagner, and L.S. Maier Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes Free Radic. Biol. Med. 63 2013 338 349
231. G.A. Figtree, C.C. Liu, S. Bibert, E.J. Hamilton, A. Garcia, C.N. White, K.K. Chia, F. Cornelius, K. Geering, and H.H. Rasmussen Reversible oxidative modification: a key mechanism of Na + -K + pump regulation Circ. Res. 105 2009 185 193
232. S. Bibert, C.C. Liu, G.A. Figtree, A. Garcia, E.J. Hamilton, F.M. Marassi, K.J. Sweadner, F. Cornelius, K. Geering, and H.H. Rasmussen FXYD proteins reverse inhibition of the Na + -K + pump mediated by glutathionylation of its beta1 subunit J. Biol. Chem. 286 2011 18562 18572
233. K.K. Galougahi, C.C. Liu, A. Garcia, N.A. Fry, E.J. Hamilton, H.H. Rasmussen, and G.A. Figtree Protein kinase-dependent oxidative regulation of the cardiac Na + -K + pump: evidence from in vivo and in vitro modulation of cell signalling J. Physiol. 591 2013 2999 3015
234. J. Ausma, G.D. Dispersyn, H. Duimel, F. Thone, L. Ver Donck, M.A. Allessie, and M. Borgers Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation J. Mol. Cell. Cardiol. 32 2000 355 364
235. R.V. Shohet, and J.A. Garcia Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia J. Mol. Med. 85 2007 1309 1315
236. A. Goette, C. Honeycutt, and J.J. Langberg Electrical remodeling in atrial fibrillation. Time course and mechanisms Circulation 94 1996 2968 2974
237. H. Bolukoglu, G.W. Goodwin, P.H. Guthrie, S.G. Carmical, T.M. Chen, and H. Taegtmeyer Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart Am. J. Physiol. 270 1996 H817 H826
238. T.N. Seagroves, H.E. Ryan, H. Lu, B.G. Wouters, M. Knapp, P. Thibault, K. Laderoute, and R.S. Johnson Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells Mol. Cell. Biol. 21 2001 3436 3444
239. A. Ahmad, S. Ahmad, B.K. Schneider, C.B. Allen, L.Y. Chang, and C.W. White Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury Am. J. Physiol. Lung Cell Mol. Physiol. 283 2002 L573 L584
240. J.W. Kim, I. Tchernyshyov, G.L. Semenza, and C.V. Dang HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metab. 3 2006 177 185